Rohan Palekar - May 12, 2022 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role
Director
Signature
/s/ Sean Smith, Attorney-in-Fact for Rohan Palekar
Stock symbol
NLTX
Transactions as of
May 12, 2022
Transactions value $
$0
Form type
4
Date filed
5/16/2022, 06:26 PM
Previous filing
Mar 4, 2022
Next filing
Sep 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NLTX Stock Option (Right to Buy) Award $0 +25K $0.00 25K May 12, 2022 Common Stock 25K $1.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/12 of the total shares monthly beginning June 12, 2022 until the option is fully vested on May 12, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.